Importantly, our mouse model allows us to compare BRCA1-deficient mammary tumors (arising in K14cre;Brca1F/F;p53F/F (KB1P) mice) with BRCA1-proficient control tumors (arising in K14cre;Brca1w. This evidence concerns the gene BRCA1 and breast cancer.